日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD: A Randomized Clinical Trial

神经塑性剂TSND-201治疗PTSD的疗效和安全性:一项随机临床试验

Jones, Amanda; Warner-Schmidt, Jennifer; Kwak, Hannah; Stogniew, Martin; Mandell, Blake; Ching, Terence H W; Stein, Murray B; Kelmendi, Benjamin

Methylone promotes neurite outgrowth and has long-lasting effects on fear extinction learning

甲基酮促进神经突生长,并对恐惧消退学习具有持久影响。

Warner-Schmidt, Jennifer; Stogniew, Martin; Mandell, Blake; Kelmendi, Benjamin

Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA

甲基酮是一种速效神经可塑性诱发剂,其脱靶活性比MDMA低。

Warner-Schmidt, Jennifer; Stogniew, Martin; Mandell, Blake; Rowland, R Scott; Schmidt, Eric F; Kelmendi, Benjamin

Correction: Discovery and clinical introduction of first-in-class imipridone ONC201

更正:首创药物咪吡啶酮 ONC201 的发现和临床应用

Allen, Joshua E; Kline, C Leah B; Prabhu, Varun V; Wagner, Jessica; Ishizawa, Jo; Madhukar, Neel; Lev, Avital; Baumeister, Marie; Zhou, Lanlan; Lulla, Amriti; Stogniew, Martin; Schalop, Lee; Benes, Cyril; Kaufman, Howard L; Pottorf, Richard S; Nallaganchu, B Rao; Olson, Gary L; Al-Mulla, Fahd; Duvic, Madeleine; Wu, Gen Sheng; Dicker, David T; Talekar, Mala K; Lim, Bora; Elemento, Olivier; Oster, Wolfgang; Bertino, Joseph; Flaherty, Keith; Wang, Michael L; Borthakur, Gautam; Andreeff, Michael; Stein, Mark; El-Deiry, Wafik S

Biological activity of weekly ONC201 in adult recurrent glioblastoma patients.

ONC201每周一次治疗成人复发性胶质母细胞瘤患者的生物活性

Arrillaga-Romany Isabel, Odia Yazmin, Prabhu Varun V, Tarapore Rohinton S, Merdinger Krystal, Stogniew Martin, Oster Wolfgang, Allen Joshua E, Mehta Minesh, Batchelor Tracy T, Wen Patrick Y

ONC201 and imipridones: Anti-cancer compounds with clinical efficacy

ONC201 和咪唑吡酮:具有临床疗效的抗癌化合物

Prabhu, Varun Vijay; Morrow, Sara; Rahman Kawakibi, Abed; Zhou, Lanlan; Ralff, Marie; Ray, Jocelyn; Jhaveri, Aakash; Ferrarini, Isacco; Lee, Young; Parker, Cassandra; Zhang, Yiqun; Borsuk, Robyn; Chang, Wen-I; Honeyman, Joshua N; Tavora, Fabio; Carneiro, Benedito; Raufi, Alexander; Huntington, Kelsey; Carlsen, Lindsey; Louie, Anna; Safran, Howard; Seyhan, Attila A; Tarapore, Rohinton S; Schalop, Lee; Stogniew, Martin; Allen, Joshua E; Oster, Wolfgang; El-Deiry, Wafik S

EXTH-70. CYP450 AND METABOLIC PROFILING OF ANTI-CANCER IMIPRIDONE ONC201

EXTH-70. 抗癌药物咪唑吡酮 ONC201 的 CYP450 和代谢谱分析

Derham, Barry K; Harding, John J; Morrow, Sara; Prabhu, Varun; Tarapore, Rohinton S; Guo, Ailan; Fang, Yunlan; Nej, Magdalena; Stogniew, Martin; Allen, Joshua

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

每周口服给药的 DRD2 拮抗剂 ONC201 在晚期实体瘤患者中的安全性和增强的免疫刺激活性

Stein, Mark N; Malhotra, Jyoti; Tarapore, Rohinton S; Malhotra, Usha; Silk, Ann W; Chan, Nancy; Rodriguez, Lorna; Aisner, Joseph; Aiken, Robert D; Mayer, Tina; Haffty, Bruce G; Newman, Jenna H; Aspromonte, Salvatore M; Bommareddy, Praveen K; Estupinian, Ricardo; Chesson, Charles B; Sadimin, Evita T; Li, Shengguo; Medina, Daniel J; Saunders, Tracie; Frankel, Melissa; Kareddula, Aparna; Damare, Sherrie; Wesolowsky, Elayne; Gabel, Christian; El-Deiry, Wafik S; Prabhu, Varun V; Allen, Joshua E; Stogniew, Martin; Oster, Wolfgang; Bertino, Joseph R; Libutti, Steven K; Mehnert, Janice M; Zloza, Andrew

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

使用选择性 DRD2 拮抗剂 ONC201 治疗儿童和成人 H3 K27M 突变型弥漫性中线胶质瘤

Chi, Andrew S; Tarapore, Rohinton S; Hall, Matthew D; Shonka, Nicole; Gardner, Sharon; Umemura, Yoshie; Sumrall, Ashley; Khatib, Ziad; Mueller, Sabine; Kline, Cassie; Zaky, Wafik; Khatua, Soumen; Weathers, Shiao-Pei; Odia, Yazmin; Niazi, Toba N; Daghistani, Doured; Cherrick, Irene; Korones, David; Karajannis, Matthias A; Kong, Xiao-Tang; Minturn, Jane; Waanders, Angela; Arillaga-Romany, Isabel; Batchelor, Tracy; Wen, Patrick Y; Merdinger, Krystal; Schalop, Lee; Stogniew, Martin; Allen, Joshua E; Oster, Wolfgang; Mehta, Minesh P

Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.

对伊米普利酮家族(临床阶段抗癌小分子 ONC201 的类似物)的临床前评估显示,ONC212 具有强大的抗癌作用

Wagner Jessica, Kline Christina Leah, Ralff Marie D, Lev Avital, Lulla Amriti, Zhou Lanlan, Olson Gary L, Nallaganchu Bhaskara Rao, Benes Cyril H, Allen Joshua E, Prabhu Varun V, Stogniew Martin, Oster Wolfgang, El-Deiry Wafik S